MRI for adenomyosis: a pictorial review, Insights Imaging. déc, vol.8, issue.6, pp.549-56, 2017. ,
, J Reprod Med. nov, vol.39, issue.11, pp.841-53, 1994.
The pathophysiology of uterine adenomyosis: an update, Fertil Steril. sept, vol.98, issue.3, pp.572-581, 2012. ,
Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis, Fertil Steril. mars, vol.109, issue.3, pp.389-97, 2018. ,
Spectrum of MR features in adenomyosis, Best Pract Res Clin Obstet Gynaecol. août, vol.20, issue.4, pp.583-602, 2006. ,
Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas, J Minim Invasive Gynecol, vol.25, issue.7, pp.1274-80, 2018. ,
Adenomyosis: review of the literature, J Minim Invasive Gynecol. août, vol.18, issue.4, pp.428-465, 2011. ,
Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy, Acta Obstet Gynecol Scand, vol.89, issue.11, pp.1374-84, 2010. ,
Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?, J Gynecol Obstet Hum Reprod. mars, vol.46, issue.3, pp.249-54, 2017. ,
Esmya ® and the PEARL studies: A review. Womens Health, vol.12, pp.544-552, 2016. ,
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery, N Engl J Med, vol.12, 2012. ,
,
, Ulipristal acetate versus leuprolide acetate for uterine fibroids, N Engl J Med. 2 févr, vol.366, issue.5, pp.421-453, 2012.
Longterm treatment of uterine fibroids with ulipristal acetate ?, Fertil Steril. juin, vol.101, issue.6, pp.1565-1573, 2014. ,
The spectrum of endometrial pathology induced by progesterone receptor modulators, Mod Pathol. mai, vol.21, issue.5, pp.591-599, 2008. ,
Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate, Expert Opin Drug Saf. déc, vol.15, issue.12, pp.1679-86, 2016. ,
Endometrial changes during ulipristal acetate use: A systematic review, Eur J Obstet Gynecol Reprod Biol. juill, vol.214, pp.56-64, 2017. ,
Uterine fibroid management: from the present to the future, Hum Reprod Update, vol.22, issue.6, pp.665-86, 2016. ,
Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids, Gynecol Endocrinol. nov, pp.1-4, 2018. ,
, Adenomyosis and Ulipristal Acetate (FRA-IIT-UPA)
The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids, Am J Obstet Gynecol. juin, vol.218, issue.6, pp.563-572, 2018. ,
Imagerie de l'adénomyose. EMC -Gynécologie-Obstétrique, août, vol.2, issue.3, pp.269-77, 2005. ,
Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging, Jpn J Radiol. juill, vol.28, issue.6, pp.430-436, 2010. ,
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, p.25 ,
, ulipristal acetate, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.31, issue.6, pp.556-69, 2012.
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program, Expert Opin Drug Saf. 2 déc, vol.17, issue.12, pp.1225-1257, 2018. ,
Liver injury and ulipristal acetate: an overstated tragedy?, Fertil Steril, vol.110, issue.4, pp.593-598, 2018. ,
MRI for adenomyosis: a pictorial review, Insights Imaging. déc, vol.8, issue.6, pp.549-56, 2017. ,
, J Reprod Med. nov, vol.39, issue.11, pp.841-53, 1994.
The pathophysiology of uterine adenomyosis: an update, Fertil Steril. sept, vol.98, issue.3, pp.572-581, 2012. ,
Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis, Fertil Steril. mars, vol.109, issue.3, pp.389-97, 2018. ,
Spectrum of MR features in adenomyosis, Best Pract Res Clin Obstet Gynaecol. août, vol.20, issue.4, p.602, 2006. ,
Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas, J Minim Invasive Gynecol, vol.25, issue.7, p.80, 2018. ,
Adenomyosis: review of the literature, J Minim Invasive Gynecol. août, vol.18, issue.4, pp.428-465, 2011. ,
Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy, Acta Obstet Gynecol Scand, vol.89, issue.11, pp.1374-84, 2010. ,
Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?, J Gynecol Obstet Hum Reprod. mars, vol.46, issue.3, pp.249-54, 2017. ,
Esmya ® and the PEARL studies: A review. Womens Health, vol.12, pp.544-552, 2016. ,
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery, N Engl J Med, vol.12, 2012. ,
Ulipristal acetate versus leuprolide acetate for uterine fibroids, N Engl J Med. 2 févr, vol.366, issue.5, pp.421-453, 2012. ,
Longterm treatment of uterine fibroids with ulipristal acetate ?, Fertil Steril. juin, vol.101, issue.6, pp.1565-1573, 2014. ,
The spectrum of endometrial pathology induced by progesterone receptor modulators, Mod Pathol. mai, vol.21, issue.5, pp.591-599, 2008. ,
Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate, Expert Opin Drug Saf. déc, vol.15, issue.12, pp.1679-86, 2016. ,
Endometrial changes during ulipristal acetate use: A systematic review, Eur J Obstet Gynecol Reprod Biol. juill, vol.214, pp.56-64, 2017. ,
Uterine fibroid management: from the present to the future, Hum Reprod Update, vol.22, issue.6, pp.665-86, 2016. ,
Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids, Gynecol Endocrinol. nov, vol.1, p.4, 2018. ,
, Adenomyosis and Ulipristal Acetate (FRA-IIT-UPA)
The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids, Am J Obstet Gynecol. juin, vol.218, issue.6, pp.563-572, 2018. ,
Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging, Jpn J Radiol. juill, vol.28, issue.6, pp.430-436, 2010. ,
Imagerie de l'adénomyose. EMCGynécologie-Obstétrique, août, vol.2, issue.3, pp.269-77, 2005. ,
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.31, issue.6, pp.556-69, 2012. ,
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program, Expert Opin Drug Saf. 2 déc, vol.17, issue.12, pp.1225-1257, 2018. ,
Liver injury and ulipristal acetate: an overstated tragedy?, Fertil Steril, vol.110, issue.4, pp.593-598, 2018. ,